Sinopharm Group Co. Ltd. logo

Sinopharm Group Co. Ltd.

SHTDY | OTC
Chart Builder DCF Calculator
$10.31
+$0.14 (+1.38%)
At close: Oct 30, 2026, 3:58 PM ET
$10.31
$0.00 (0.00%)
After-hours: Oct 30, 2026, 4:00 PM ET

Company Profile

Sinopharm Group Co. Ltd. is a prominent Chinese enterprise specializing in the wholesale and retail of pharmaceuticals, medical devices, and other healthcare products. The company's diverse operations are structured into four key segments. The Pharmaceutical Distribution segment is responsible for supplying a wide array of pharmaceutical products to various healthcare entities, including hospitals, clinics, and retail pharmacies. This segment also provides comprehensive logistics and value-added services to both domestic and international manufacturers and suppliers of pharmaceutical and healthcare items. The Medical Devices segment focuses specifically on the distribution of medical equipment. Through its Retail Pharmacy segment, the company operates and franchises an extensive chain of drugstores, which totaled 10,259 locations as of December 31, 2021. The Other Business segment encompasses the manufacturing and sale of pharmaceutical products, chemical reagents, and laboratory supplies. Beyond these core activities, Sinopharm Group also engages in property rental and management, distributes specialized products such as Chinese herbal medicines, antibiotics, and biological products, and offers a suite of services. These include IT development, medicine, business, health, and market information consulting, international trade (import/export of goods and technology), market investigation, and convention and exhibition services. Furthermore, the company is involved in medical project investment, consulting, and technology training. To enhance its commercial capabilities and transformation, Sinopharm Group Co. Ltd. maintains a strategic partnership with I-Mab. Founded in 2003, the company is headquartered in Shanghai, China, and operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Key Executives

Name Position
Xiaojuan Li Chief Financial Officer
Binghua Yang Executive Director
Wanyong Lian President & Executive Director
Yijian Wu Vice President, Secretary to the Board & Company Secretary
Sinopharm Group Co. Ltd.
Sinopharm Group Co. Ltd. logo
Country China
IPO Date Aug 25, 2016
Industry Medical - Distribution
Sector Healthcare
Employees 94,910
CEO Wanyong Lian

Contact Details

Sinopharm Group Building Shanghai, SH 200023 China

Stock Details

Ticker Symbol SHTDY
Exchange OTC
Fiscal Year n/a
Reporting Currency USD
CIK Code n/a
CUSIP Number 82937K101
ISIN Number US82937K1016
SIC Code n/a

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.